Feasibility Study of Managing Cancer And Living Meaningfully CALM Therapy for Women With Newly Diagnosed or Recurrent Advanced Ovarian Cancer

What this Trial Is About

This trial is studying the feasibility and acceptability of a brief psychotherapeutic intervention called Managing Cancer And Living Meaningfully CALM for patients newly diagnosed or recently recurred with advanced ovarian cancer stage III or IV. The study aims to find out if CALM can be implemented around the time of diagnosis or recurrence and to understand the baseline prevalence of traumatic stress symptoms in these patients. The findings may help plan a larger trial to assess CALMs effectiveness. Participants will receive 3 to 6 sessions of CALM therapy over 3 to 6 months. CALM is a supportive-expressive therapy focused on symptom management, relationships, meaning in life, and hopes or fears about the future. This therapy is delivered individually or with a caregiver, with sessions lasting 30 to 60 minutes each. The study includes about 100 patients divided equally between newly diagnosed and recently recurred ovarian cancer groups. Participants are asked to complete questionnaires at baseline, 3 months, and 6 months to measure stress reactions and satisfaction with CALM therapy. Additional questionnaires assess symptoms, depression, attachment experiences, and distress related to death and dying. Some participants may also be interviewed after 6 months. The total participation time is up to 6 months, with ongoing assessments to monitor outcomes and gather feedback on the therapy.

Feasibility of CALM in Patients With Ovarian Cancer